ES2195653T3 - Compuesto de s-oxido que disminuyen los lipidos. - Google Patents

Compuesto de s-oxido que disminuyen los lipidos.

Info

Publication number
ES2195653T3
ES2195653T3 ES99964594T ES99964594T ES2195653T3 ES 2195653 T3 ES2195653 T3 ES 2195653T3 ES 99964594 T ES99964594 T ES 99964594T ES 99964594 T ES99964594 T ES 99964594T ES 2195653 T3 ES2195653 T3 ES 2195653T3
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
formula
lipides
decrease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99964594T
Other languages
English (en)
Inventor
Cornelus Gerardus Mari Janssen
Peter Walter Maria Roevens
Jozef Bertha August Thijssen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2195653T3 publication Critical patent/ES2195653T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de fórmula (I) **(Fórmula)** sus N - óxidos, sus formas estereoquímicamente isómeras, y sus sales de adición de ácido farmacéuticamente aceptables, en la cual n es 1 ó 2; R1 es hidrógeno, C1-6 alquilo o halo; R2 es hidrógeno o halo; R3 es C1-8 alquilo o C 3 - 6 cicloalquilo; Het es un radical de fórmula **(Fórmula)** en las cuales R4 es hidrógeno, C1-4 alquilo, trifluorometilo, amino o hidroxi; R5 es hidrógeno o C1-4 alquilo; R6 es hidrógeno o C1-4 alquilo; y - A - B - es un radical bivalente de fórmula - CH=CH - (b - 1) - N=CH - (b -2) - CH=N - (b - 3) en las cuales opcionalmente uno de los átomos de hidrógeno está reemplazado por C1-4 alquilo.
ES99964594T 1998-12-22 1999-12-14 Compuesto de s-oxido que disminuyen los lipidos. Expired - Lifetime ES2195653T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98204410 1998-12-22

Publications (1)

Publication Number Publication Date
ES2195653T3 true ES2195653T3 (es) 2003-12-01

Family

ID=8234538

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99964594T Expired - Lifetime ES2195653T3 (es) 1998-12-22 1999-12-14 Compuesto de s-oxido que disminuyen los lipidos.

Country Status (12)

Country Link
US (1) US6451802B1 (es)
EP (1) EP1140917B1 (es)
JP (1) JP2002533339A (es)
AR (1) AR021969A1 (es)
AT (1) ATE235487T1 (es)
AU (1) AU761032B2 (es)
CA (1) CA2355822A1 (es)
DE (1) DE69906376T2 (es)
ES (1) ES2195653T3 (es)
MY (1) MY130851A (es)
NZ (1) NZ512891A (es)
WO (1) WO2000037463A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080280922A1 (en) * 2004-04-09 2008-11-13 Marc Alois Celine Maria Engelen Intermittent Dosing Regimen For Overweight and Obese Subjects
CA2609783A1 (en) * 2005-05-27 2006-12-07 Pfizer Products Inc. Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
ES2348530T3 (es) 2007-05-25 2010-12-09 Janssen Pharmaceutica, N.V. Síntesis mejorada de metanosulfonato de (2s-cis)-2-(bromometil)-2-(4-clorofenil)-1,3 dioxolan-4-metanol (éster).
US9790104B2 (en) * 2012-02-17 2017-10-17 Hydrafact Limited Water treatment
EP3066098A1 (de) 2013-11-08 2016-09-14 Bayer Pharma Aktiengesellschaft Substituierte uracile und ihre verwendung
CN111100112B (zh) * 2018-10-29 2021-05-04 浙江京新药业股份有限公司 苯并噻吩衍生物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013499A1 (en) * 1994-10-27 1996-05-09 Janssen Pharmaceutica N.V. Apolipoprotein-b synthesis inhibitors

Also Published As

Publication number Publication date
AU3039500A (en) 2000-07-12
EP1140917A1 (en) 2001-10-10
EP1140917B1 (en) 2003-03-26
DE69906376T2 (de) 2004-02-12
WO2000037463A1 (en) 2000-06-29
MY130851A (en) 2007-07-31
ATE235487T1 (de) 2003-04-15
US6451802B1 (en) 2002-09-17
AU761032B2 (en) 2003-05-29
AR021969A1 (es) 2002-09-04
NZ512891A (en) 2003-01-31
JP2002533339A (ja) 2002-10-08
DE69906376D1 (de) 2003-04-30
CA2355822A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
HK1079191A1 (en) Pleuromutilin derivatives as antimicrobbials
NO166129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-9h-pyrido (3,4-b)indoler.
AR039689A1 (es) Difenilazetidinonas sustituidas, medicamentos que comprenden estos compuestos y su uso
MX9202287A (es) Nuevos derivados de perhidroisoindol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK0554543T3 (da) 1,2,4-triaminobenzenderivater og fremgangsmåde til deres fremstilling
HRP20000006B1 (en) Gastrocinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
AR069309A1 (es) Derivados de imidazo[1,2-a] piridina moduladores alostericos positivos de receptores mglur2, composiciones farmaceuticas que los contienen y usos de los mismos en el tratamiento de trastornos neurologicos y psiquiatricos.
CO5700776A2 (es) Compuestos utiles para el tratamiento de enfermedades
BG104499A (en) Retinoic acid mimetic anilides
BR0210077A (pt) Composto, seus sais, solvatos e ésteres hidrolisáveis farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar alfa
TW341571B (en) Sulfonamide derivatives of azolones
CO6260099A2 (es) Depsipeptidos ciclicos
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
ES2195653T3 (es) Compuesto de s-oxido que disminuyen los lipidos.
DK0657422T3 (da) Naphthyloxyeddikesyrederivater som PEG2-agonister og -antagonister
DK0497121T3 (da) Hidtil ukendte tetrazolderivater, fremgangsmåde til fremstilling af disse og anvendelsen af disse
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
HUP9801339A1 (hu) Legyengült állapotok javítására alkalmas béta-adrenerg agonista hatású vegyületek
CO4990971A1 (es) Agentes terapeuticos selectivos de la mmp-3, especialmente con una buena selecti vidad con respecto a las mmp-1,2,9y/o 14
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
DK0646578T3 (da) Phenylcarboxamidisoxazoler og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmace
NZ505614A (en) Pentasaccharides and pharmaceutical compositions thereof, useful as anti blood clotting agnets
HUP0301024A2 (hu) Szinergetikus hatású fungicid készítmények és alkalmazásuk
NO954938D0 (no) Antiallergiske imidazoazepiner